In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1931 News Items found
Memorial Sloan Kettering medical oncologist Eileen O'Reilly
Vaccine Targeting KRAS in Pancreatic Cancer Shows Promise

Read about a therapeutic vaccine that could potentially prevent certain pancreatic cancers from returning.
Detail of a researcher working in an MSK lab
MSK Research Highlights, October 22, 2026

New MSK research shows how genes activate across vast distances inside a cell; identifies a new form of cell death that could open new opportunities for cancer therapy; uncovers hidden genetics involved in autism; develops an AI tool that can predict a cell’s fate and help change it; and finds STAT3 acts as an inflammation-sensing switch in natural killer cells.
Dr. June Lee and Dr. Genovefa Papanicolaou
FDA Approves Pritelivir To Treat Herpes Infections in Immunocompromised Patients

The FDA has approved pritelivir for treating herpes simplex virus in immunocompromised patients, including those who are undergoing cancer treatment.
Adrianna Gildner, thyroid cancer patient, wearing orange Fred’s Team shirt, smiling and giving thumbs up in Italy.
Article
Targeted Therapy for Thyroid Cancer Helps Save a Young Voice

Learn how a young woman with thyroid cancer avoided extensive surgery due to MSK's treatment expertise.
Four people treated for rectal cancer in a clinical trial at MSK are seen outdoors with the trial’s two principal investigators.
FDA Approves Immunotherapy-Only Approach for Some Rectal Cancers: What Patients Need To Know

The FDA approved a treatment for rectal cancer tumors with a specific genetic signature that uses only the immunotherapy Jemperli, allowing some patients to be successfully treated without surgery, radiation, or chemotherapy.
A gloved hand holds a petri dish
Gerstner Sloan Kettering Graduate Students Receive 2026-2027 Fellowships

A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.
Michelle Villagomez, a patient treated at MSK for metaplastic breast cancer
How MSK’s Expertise Treated a Rare Metaplastic Breast Cancer

Patients like Michelle benefit from the specialized skills of experts in MSK’s Rare Breast Cancer Program.
a doctor and patient review a scan
Insights About Cachexia, One of Cancer’s Most Common Complications, Hiding in Routine Patient Data

Wasting — called cachexia — affects about half of all cancer patients. An MSK analysis of clinical data from more than 60,000 cancer patients is shedding new light on the condition.
an MSK researcher looks through a microscope
MSK Research Highlights, October 9, 2026

New MSK research uncovers an unknown role for immune cells in fueling triple-negative breast cancer; identifies a new strategy for fighting leptomeningeal metastases; finds trastuzumab deruxtecan shows enhanced benefit for patients with ERBB2 mutations in breast cancer; shows tumor DNA insights can help guide treatment for patients with hard-to-treat biliary tract cancers; and uses artificial intelligence (AI) to study early development.
Dr. Zsofia Stadler smiles while leaning on a desk and wearing a stethoscope around her neck
Study Suggests Every Cancer Patient Should Be Tested for Inherited Cancer Mutations

A new MSK study has found that hereditary cancers are much more common than expected in patients over age 50, suggesting that everyone with cancer should be tested for these mutations.